These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25994655)

  • 1. PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.
    Mestre L; Redondo M; Carrillo-Salinas FJ; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Gil C; Martínez A; Guaza C
    Br J Pharmacol; 2015 Sep; 172(17):4277-90. PubMed ID: 25994655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
    González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
    Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis.
    Benítez-Fernández R; Gil C; Guaza C; Mestre L; Martínez A
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.
    Martín-Álvarez R; Paúl-Fernández N; Palomo V; Gil C; Martínez A; Mengod G
    J Chem Neuroanat; 2017 Mar; 80():27-36. PubMed ID: 28007551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury.
    Paterniti I; Mazzon E; Gil C; Impellizzeri D; Palomo V; Redondo M; Perez DI; Esposito E; Martinez A; Cuzzocrea S
    PLoS One; 2011 Jan; 6(1):e15937. PubMed ID: 21297958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.
    Redondo M; Brea J; Perez DI; Soteras I; Val C; Perez C; Morales-García JA; Alonso-Gil S; Paul-Fernandez N; Martin-Alvarez R; Cadavid MI; Loza MI; Perez-Castillo A; Mengod G; Campillo NE; Martinez A; Gil C
    J Med Chem; 2012 Apr; 55(7):3274-84. PubMed ID: 22385507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
    Redondo M; Palomo V; Brea J; Pérez DI; Martín-Álvarez R; Pérez C; Paúl-Fernández N; Conde S; Cadavid MI; Loza MI; Mengod G; Martínez A; Gil C; Campillo NE
    ACS Chem Neurosci; 2012 Oct; 3(10):793-803. PubMed ID: 23077723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases.
    Chen Y; Wang H; Wang WZ; Wang D; Skaggs K; Zhang HT
    Neuropharmacology; 2021 Sep; 196():108694. PubMed ID: 34245775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research.
    Jankowska A; Swierczek A; Chlon-Rzepa G; Pawlowski M; Wyska E
    Curr Med Chem; 2017; 24(7):673-700. PubMed ID: 28093982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.
    Ortega-Gutiérrez S; Molina-Holgado E; Arévalo-Martín A; Correa F; Viso A; López-Rodríguez ML; Di Marzo V; Guaza C
    FASEB J; 2005 Aug; 19(10):1338-40. PubMed ID: 15941768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
    Medina-Rodríguez EM; Arenzana FJ; Pastor J; Redondo M; Palomo V; García de Sola R; Gil C; Martínez A; Bribián A; de Castro F
    Cell Mol Life Sci; 2013 Sep; 70(18):3449-62. PubMed ID: 23661015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions.
    Szczypka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
    Redondo M; Soteras I; Brea J; González-García A; Cadavid MI; Loza MI; Martinez A; Gil C; Campillo NE
    Eur J Med Chem; 2013; 70():781-8. PubMed ID: 24239625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
    Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
    Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
    Li L; Ulrich R; Baumgärtner W; Gerhauser I
    J Neuroinflammation; 2015 Dec; 12():242. PubMed ID: 26703877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
    Redondo M; Zarruk JG; Ceballos P; Pérez DI; Pérez C; Perez-Castillo A; Moro MA; Brea J; Val C; Cadavid MI; Loza MI; Campillo NE; Martínez A; Gil C
    Eur J Med Chem; 2012 Jan; 47(1):175-85. PubMed ID: 22100138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors.
    Malik R; Bora RS; Gupta D; Sharma P; Arya R; Chaudhary S; Saini KS
    Appl Microbiol Biotechnol; 2008 Jan; 77(5):1167-73. PubMed ID: 17952431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.